WALD

Q&A · close

When do you expect the Business Combination to be completed? A: It is currently expected that the Business Combination will be consummated in the first half of 2022. This date depends, among other things, on the approval of the proposals to be put to Waldencast shareholders at the extraordinary general meeting. However, such meeting could be adjourned if the Adjournment Proposal is adopted by Waldencast s shareholders at the extraordinary general meeting and Waldencast elects to adjourn the extraordinary general meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the extraordinary general meeting. For a description of the conditions for the completion of the Business Combination, see the sections entitled BCA Proposal Obagi Merger Proposal The Obagi Merger Agreement and BCA Proposal Milk Transaction Proposal The Milk Equity Purchase Agreement .

Q&A · meeting

When and where will the extraordinary general meeting be held? The extraordinary general meeting will be held at , Eastern Time, on , 2022, at the offices of Skadden, Arps, Slate, Meagher amp; Flom LLP located at One Manhattan West, New York, NY 10001, or virtually via live webcast at https://www.cstproxy.com/waldencast/2022, or such other date, time and place to which such meeting may be adjourned or postponed, to consider and vote upon the proposals.